Genome-Wide Prediction of Vaccine Candidates for Leishmania major: An Integrated Approach

Table 5

The distribution of fractional immunogenicity for the 45 optimal epitopes against the population of North Africa.

S. number	Epitope	Fraction of overall immunogenicity	Covered alleles
1	SLWSLLAGV	0.09	A0201
2	YMDPGAAGY	0.09	A0101
3	YLLDGDQLI	0.07	A0201
4	TPRIPLDSL	0.05	B0702 B0801 B3501
5	LPRLFLAFL	0.05	B0702 B0801 B3501
6	FIDANTAIY	0.05	A0101
7	VESGALFSF	0.04	B4403
8	VLVGVVLGV	0.04	A0201
9	TLFPIDVTV	0.04	A0201
10	ELRRRGQEV	0.04	B0801
11	GYPNINTYL	0.03	A2402
12	LYLLLPFLL	0.03	A2402
13	LMAAMLVAV	0.03	A0201
14	FPISKGAAL	0.03	B0702 B0801 B3501
15	FLFSPTDTL	0.03	A0201
16	GYIVVDKYF	0.03	A2402
17	MLPDMTCSL	0.02	A0201
18	SLFRVANCK	0.02	A0301
19	APAAPHSPL	0.02	B0702 B3501
20	RPRLFARAI	0.01	B0702 B3501 B5101
21	ALYTSIPVR	0.01	A0301 A3101
22	APALYTISL	0.01	B0702 B3501
23	APNYYLTPL	0.01	B0702 B3501
24	APAHGSVSL	0.01	B0702 B3501
25	FVRVWDRSL	0.01	B0702 B0801
26	STQPPVSSW	0.01	B5801
27	LVHAGIAGK	0.01	A1101 A6801
28	LTSAINQFW	0.01	B5801
29	GTFAAPLRW	0.01	B5801
30	AYFVVPLEM	0.01	A2402
31	SPTPLLAAL	0.01	B0702 B3501
32	TPSSARLSM	0.01	B0702 B3501
33	MSLFVSTLF	0.01	B5801
34	GYMPTASFK	0.01	A1101
35	STVLRLFSF	0.01	B5801
36	YLCDRTTAA	0.01	A0201
37	NLAAGQSLK	<0.01	A0301
38	TMPTAPSSK	<0.01	A0301
39	VSGGSTVSF	<0.01	B5801
40	SAAAPYSLW	<0.01	B5801
41	RELQSVYLL	<0.01	B4403
42	SFDDYTMVL	<0.01	A2402
43	LFLLVIYAF	<0.01	A2402
44	RIKRNWQKK	<0.01	A1101
45	LLPRLFLAF	<0.01	A0301